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Melanotnas develop with high frequency in trans-
genic tnice in which oncogenic sequences of the SV 40 
DNA tutnor virus have been specifically targeted to 
tnelanocytes. To investigate the role ofSV40 in tnela-
notnagenesis, cultured hutnan tnelanocytes were 
transfortned with a retroviral shuttle vector encoding 
the SV 40 large T antigen and exatnined for changes 
in cell-cycle kinetics and growth-factor dependence. 
Colonies expressing the viral oncogene were tnor-
phologically indistinguishable frOtn their non-T-an-
tigen-transfortned counterparts. Also like nortnal 
tnelanocytes, the infected cells retnained anchorage 
dependent and non-tutnorigenic in nude tnice. How-
ever, T-antigen-positive cultures exhibited signifi-
cantly accelerated population doubling titnes, in-
creased saturation densities with highly confluent 
E pidermal melanocytes are subject to a highly complex ne twork of heterogeneous activators and inhibitors that regulate their entrance and progression through the cell cycle [1,2]. Targets of these various stimuli are genet-ically determined positive (i .e., ras oncogene) [1,3,4] or 
negative (i.e. , p53 and Rb tumor suppressor genes) [5,6] inducers of 
cellular proliferation and growth-factor expression . Mutations within 
these la tter regulatory elements are particularly inclined to destabilize 
tlus complex system ,md may playa critical role in tl1e pathogenesis of 
melanoma or its distinctive precursor lesions [1,3,5,6]. 
Similar sta tes of imbalance between cell-cycle regulatory ele-
ments have been shown to occur when ceLIs are transfected with 
certai]l vira l genes with transfonning capabilities [4,7-1.0]. Because 
viruses depend on the host-cell machinery for their own develop-
ment and multiplication, they may induce the expression of 
growth-regulating genes and may be particularly informative in 
revealing essential elements in the carcinogenesis process . The 
SV40 large T antigen, the dominant oncogenic protein expressed 
by thc SV40 DNA tumor virus, is able to form stable, and 
functionally inactive, complexes with host-cell proteins that act 
specifically as proliferation inhibitors [7,11-14]. With inactivation 
Manuscript rcceived September 2, 1994 ; revised December 1, 1994; 
accepted for publ.ication January 20. 1995. 
Reprint requests to : Dr. Craig A. Elmets, Department of Dermatology, 
Case Western Reserve University, 11100 Eucl.id Avenue, Cleveland. OH 
44106. 
tnonolayers and a three- to fourfold extended life 
span. Most interestingly, cell-cycle analysis revealed 
a measurable shift from quiescent to cycling cells in 
T-antigen-expressing cultures and an acquired abil-
ity to progress more rapidly through G1. Moreover, 
T -antigen-positive melanocytes proliferated in the 
absence of PMA and required markedly reduced lev-
els of exogenous bFGF. These studies indicate that 
the viral oncogen of simian virus 40 provides mela-
nocytes with distinct growth advantages that may 
render these cells unusually susceptible to additional 
environmental challenges necessary for full expres-
sion of the malignant phenotype. Key words: ollcoge"el 
t,mlor sJlppressor gelleslp53lmela"otllalcell cu'tJlre. ] I"vest 
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of such key tumor-suppressor gene products as p53 and Rb 
[7,11-14], the SV40 large T antigen may force the infected cell to 
increase nucleotide metabolism and DNA synthesis, thus providing 
an appropriate intracellular environment for its own replication 
[15] . The pleiotropic effects of large T-antigen expression on the 
growth, differentiation, and malignant potential of human epider-
mal melanocytes has received little attention [16,17]. Tlus is 
somewhat surprising because m elanocytes not only provide an 
excellent model system with wluch to examine positive and 
negative influences on cell growth and differentiation, but also have 
received considerable attention as a model for neoplastic develop-
m ent [17,18]. Moreover, in transgenic mice, susceptibility to 
cutaneous melanoma can be conferred by targeting the SV40 
traJlsgene to m elanocytes with the tyrosinase promoter [19,20]. In 
the present study, we focused on proliferative features and ccll-
cycle kinetics of SV 40 large T -antigen-transformed adult human 
melanocytes, addressing the question of whether transformation of 
normal melanocytes with the SV40 large T antigen altered specific 
growth patterns and cell-cyclc kinetics. Our findings indicate that 
thc SV40 large T-antigen augments progression of melanocytes 
through the cell cycle and reduces their requirement for basic 
fibroblast growth factor (bFGF) an essential melanocyte mitogcn. 
However, the cells do not tmdergo complete transformation to the 
malignant phenotype. These features suggest that introduction of 
SV 40 large T antigen into melanocytes produces an intcrmediate 
• stage between the nornlal and malignant cell, which may be useful 
for delineating key events in the melanomagenesis pathway. 
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MATERIALS AND METHODS 
Cell Culture Adult melanocyte cultures from cadaver sJcin were estab-
lished according to a protocol developed in our laboratory. Specimens of 
skin were incubated overnight at 4°C in 0.5% dispase (Boehringer Mann-
he im Biochemicals, Indianapolis, IN). Epidermal layers were peeled off and 
wcre further disaggregated in 0.15% trypsin (Sigma Chemica l Co., St. 
Louis, MO) at 37°C. The resulting cell suspension, consisting mainly of 
keratinocytes and melanocytes, was passed through a tissue sieve and a fine 
needle to obtain single cell s. Careful epidermal preparation and the 
utiliza tion of serum-fTee medium prevented contamination with dermal 
fibroblasts. Primary cu ltures were establi shed by placing the ce ll suspension 
in modified MCDB1 53 medium supplemcnted with 1 ng/ ml bFGF, 0.4% 
(v i v) bovine pituitary extract (BpE), 10 ng/ml phorbol myristate acetate 
(pMA), 100 U/ml penicillin, 100 fLg /m l sO'eptomycin (all components from 
Gibco, Grand Island, New York), and 2 mM CaCI2. The relatively high 
calcium concentration led to terminal keratinocyte differentiation thereby 
selecting for melanocytes. Pure populations were usuaUy obta ined by the 
second passage. Melanocytes were fed biweekly and passaged every 6-8 d. 
The melanoma cell line SK-MEL 28 (American Type Culture Collection, 
Ardmore , OK) was maintained in Dulbecco's modified Eagle's medium 
with 10'1., fetal bovine serum (FBS) (Hyclone Laboratories Inc., Logan, 
UT), 100 U / ml penicillin, and 100 fLg/ml streptomycin (Gibco BRL, 
Gaithe rsburg, MD). All microscopic photographs were taken with a Nikon 
FX-35 OX camera atmched to a Nikon UFX-DX microscope. 
Retroviral Transformation and Identification of Transformants 
The replication-defective retroviral vector pZIPTEX. encoding both the 
SV 40 large T gene and the bacte rial neomycin resistance gene, was based on 
the pZIP-Neo SV(X)L vector [21]. The virus was transfected into 'VCRJP 
cells carrying a mutant Moloney leukemia virus stably integrated in to their 
genome. Lacking the essential "1)1 site to be packaged into virions, the helper 
virus itself cannot be propagated, but provides aU obligate trans functions to 
produce high titers of infectious replication-defective retrovira l particles. 
The tra nsfected packaging cell line was kind ly provided by Dr. J. Jacob-
bergcr [21]. Packag ing cclls were cloned in 800 fLg/ml G418 (Gibco) 
containing medium prior to the transformation experiments to ensure 
retrovi ral integration. Retrovirus conta ining supernatant was co llected 24 h 
after medium change , filtered thro ugh a 0.22-fLm filter (Gelman Sciences, 
Ann Arbor, Ml) and supplemented with 4 fLg polybrene/ml (Sigma) to 
faci litate virus attachment to the host cell s. 5 X 105 meLanocytes from the 
second passage were seedcd on 10-cm petri dishes 36 h prior to transfor-
mation. Medium was replaced with infectious supernatant and cells repeat-
edly incubated for 2 h at 37°C, add ing fresh virus-containing medium each 
time. Forty-eight hours post-infection. melanocytes were exposed to 400 
fLg/m l G4 18 in culture medium and resistant colonies were expanded 
during the foll owing weeks. 
Cell Fixation, Staining, and Flow Cytometry Flow-cytomctric ana l-
ysi s was used to detcct SV40 large T - antigcn cxpression in transformcd 
melanocytes and to determine the ccll-cycle distribution in normal and 
T -an tigen-positive melanocytes. Onc million ce lls per sample werc fixed 
with methanol at - 20°C, incubated with 1 fLg of mouse anti-SV 40 large T 
antigen antibody diluted in 50 fLI (pAb416, Oncogene Science. Manhasset. 
NY) , fo llowcd by staining with goat anti-mouse IgG F(ab') 2 fragmc nts 
conjugated to fluorescein (Boehringer Mannheim). For DNA mCOlsurc-
mcnts. ce ll s were placed in 150 fLI phosphatc- bufFcred sa line (PBS) con ta in-
ing RNase A (0 .04 Kunitz units/sample) for 30 min . At the end of the 
incuba tion period 500 fLI of PBS conta ining 100 Il-g/m l propidium iodide 
was added 12 1]. Analyses were perfon11ed on a flow cytometer (Cytoflu-
orograph li s; Ortho Instruments, Wcstwood. MA). usiug the 488-nm linc 
of an argon laser o perating at 250 m W. Green fluoresccnce was co llected 
through a 530/20-nm bandpass filter set, and red fluorescence was co llectcd 
above 640 nm . A doublet d iscriminator (peak vcrsus in tegrated signa l) as the 
primary gatc cxcludcd ce ll aggregates . Immunofluorescence was logarith-
mically amplified and at least I 0,000 ce ll s were ana lyzed per sample . The 
percentage of the tota l cell population present in Gl or G2 + M was 
calculated from DNA histograms using thc C icero software (Verity Soft-
ware H o use, Topsham . ME) . Results reprcsent Olverages of at least three 
indepcndently conducted experiments using passage-matched ceUs of dif-· 
fercnt donors. 
Cell Cycle Inhibitors Aphidicolin (Sigma) , a potent inhibitor of DNA 
synthesis (S phase), was di ssolved in dimethyl sulfoxide (Sigma) at a 
concentration of 1.5 m g/ml and used at a concentration of 1 fLg / ml. 
Colcemid (Gibco). which prevents completion of mitosis (G2IM phase). 
was added to the medium at 0.2 Il-g/ ml. In pre liminary experiments, the 
drugs were titrated to determine the minimal concentration necessary to 
yie ld the maximum fra ction of cel ls in the indica ted compartment. 
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Growth Kinetics Proliferation of normal and T-antigen-positive mela-
nocytes and melanoma cell s under varying culture conditions (regarding ce ll 
densiry aJld bFGF supply) was assessed. For each condition, defined 
numbers of cell s were seeded in triplica tes in 24-wcll plates, were collected 
by trypsinization and were counted in a hemocytometer. Population 
doubling times were calculated from the slope of the log-phase curves. To 
quant:ify saturation densities in the respective cultures, ce ll s were g rown 
until no further increase in confluence could be observed. They were then 
harve sted by trypsinization and coun ted. Saturation densities are expressed 
as total numbers of cells/cm2 growth surface. 
Melanin Content Relativc melanjn contents of the different cell lines 
were determined by heating pellets of 10" ceUs pe r sample, in 1 ml 0.1 M 
NaOf-l. at 95°C fo r 90 min. T hc optica l density of the supernatants was 
measured at 475 nm with a Beckn"mn DU 640 spectrophotometcr and 
fibroblasts at similar cell numbers served as a blank standard. 
Northern Blot Hybridization Expression of tyrosinase ml~A was 
deter111ined by a standard RNA hybridization procedure [22]. Ten micro-
grams of total cellular I~A from normal and T-antigen-transfon11ed 
melaoocytes and from melanoma cells was separated on a denaturing 1.4% 
agarose gel, transferred to a nylon membrane, and ultraviolet crosslinked. 
The gene-spec ifi c probe consisted of a 1.6-kb cDNA clone of the human 
tyrosinase gene inserted at the Eco R.I site of a plasmid vector (pMEL34, a 
kind gift of R. Halaban [22]) and was labeled with 32p using the random 
ol.igo priming method (Gibco DIU). 
Detection of bFGF Protein FoHowing detergent lysis (1 % Triton 
X-l00) of each 5 X 10" cell s, 30 fLg soluble protein sample was subjected 
to 12')1" sodium dodecylsulfate-polyacrylamide gel e lectrophoresis (SDS-
PAGE ) and electrotransfer on a nitroce llulose membrane. Aftcr blocking of 
nonspecific binding sites, the membranes were incubated with a monoclonal 
rabbit anti-human bFGF antibody (Sigma) and bands were visualized using 
the DAKO AEC-substrate systcm (DAKO, Carpintcria, CA). 
Ancborage-Independent Growth Six-weH plates , covered with 1 mil 
well 0 .5% agar (Difco Laboratories. Detroit, MI) in cu lture medium. were 
overlaid with 1 mllwell of a 0.3% agar suspension containjng e ither 10' or 
10· cells/ml and 10% FBS. O ne milliliter of culture medium was added 
week:.ly and the developmcnt of colonies was observed over a period of 3 
weeks. Groups of more than 30 cell s were considercd as colonies. Aggre-
gates of cell s present during thc initial plating process were marked and 
disregarded. 
Tu~origenicity in Nude Mice To evaluate malignant tfallSformation, 
1 06 '"('-an tigen- expressing melanocytes in 100 fLI steril e I-lank's balanced sa lt 
solu t:ion were injected subcutan eously into the subscapular region of 
4-6-week-old female athym ic mice (Animal Research Faci li ty, CWRU). 
ConlAol anjmals rece ived iden tica l numbers of either normalmclanocytcs or 
tumor ce ll s in the same preparation. Each g ro up consisted of five mice. 
Anir!'",ls wcre examiJled for tumor formation at rcgular intervals for 20 
wcel""s. 
RESULTS 
Isolation and Characterization of T -Antigen-Expressing 
Tra:nsformants SV 40 large T -antigen-transformed m e lanocytes 
were isolated by incubating second passage cu ltures in the logarith-
mic growth phase with infectious, virus containing supernatant. 
Within 10-1.4 d, drug-resistant colonies were clearly visible, 
further expanded ell lIIasse, and T-antigen expression monitored by 
fluo~escence-activated ce ll sorter analysis. On ly cultures that were 
100(% positive for T -antigen express ion were subjected to experi-
merJ.ta.1 c onditions . S100 and DOPA stains confirmed the melano-
cytie origin of the transformants and the abse n ce of keratinocytes 
and fibroblasts (data not shown). 
Although slightly larger with increased cell body volume, T-
antigen-expressing melanocytes remaiJl e d morphologically un-
ch anged upon transformation. Like their non-transformed counter-
partS, they displayed th e typical features of cu ltured melanocytes 
witl'! bi- and multipolar dendrites (Fig 1). Melanoma cell s, su c h as 
the spindl e-shaped SK-MEL 28 lin e, frequently lose this c h aracter-
istic appearance. C ultured human melanocytes displayed a charac-
teri5tic growth pattern of regularly distributed cells that formed a 
network of dendritic contacts, but rare ly overlapped and u su ally 
stopped dividing when cell s reached 70-80'10 confluence. In strik-
ing contrast to this apparent contact inhibition, SV40 large T-
antigen-transformed melanocytes formed tightly packed monolay-
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Figure 1. SV40 T-antigen-transformed melanocytes remain mor-
phologically unchanged. The photomicrographs show semicol1Auent 
cultures of (a) normal human melanocytes at passage three and (b) SV 40 
T _antigen-transformed melanocytes, second-passage post-transfection . 
Bars, 15 ILm . 
e rs with continuing proliferative acavlty . T h e cells within these 
hyperconAu ent cu ltures were mostly bipolar and frequen tly over-
lapped (Fig 2). 
As confirmed by positive DOPA reaction, SV40 large T-antigen-
transfonned melanocytes continued to produce melanin, but, as 
determined by measurements of the rela tive opticaJ densities of 
these pellets, showed 6.5 times lower absorption values compared 
to naive cells (optical density values: fibroblasts 0.008, SK-MEL28 
0.009, T-antigen-transform ed melanocytes 0.065, normalmelano-
cytes 0.559). T hese findin gs corresponded to the results of North-
em blot analyses, which showed high levels of tyrosin ase n1.RNA in 
non-transform ed melanocytes and a significantly weaker signal in 
T-antigen- positive cells. No detectable tyrosin ase mRNA was 
found in extracts of SK-Mel 28 melanoma cultures (Fig 3). 
SV40 Large T Antigen Increases the Mitotic Fraction of 
Transfected Cultures and Accelerates Their Progress 
Through the Cell Cycle As calcu lated from third-passage 
cultures, the average cell yield after 8 d of culture was 15.9 :!::: 1.59 
X 10" cells/cm 2 for T-antigen-positive cells compared to 5.8 ± 
0.53 X 10" cells/cm2 for non- transform ed m elanocytes, indicating 
that th e: growth ofSV40 transformed m elanocytes was substaotially 
enhanced . 
To de termine whether SV 40 large T -antigen expression jnAu-
enced the percentage of mitotic cells within the populatioo, the 
ON A distribu tion pattern in normal and transformed cultu res at 
SV40 LARGE T-ANTIGEN-TRANSFORMED MELANOCYTES 757 
Figure 2. SV40 T-antigen expression increases the saturation den-
sity of hum all melanocytes. Cells were plated at 4 X 103 cells/cm2 and 
continuously grown without passagin g. T he phase photomicrographs depict 
the typical appearance of a) nOll-transformed melanocytes at saturation 
density with an even di stribution of cells d,at rarely overlapped. b) In 
con trast, T - antigen-positive melanocytes formed tigh dy packed monolay-
ers. Bars, 100 ILm . 
varying densities was assessed. T his was accomplished by plating 
cells and harvesting them after two population doubling tinles (i.e., 
72 h for T-antigen- transfonned cells and 96 h for nomlal melano-
cytes, respectively). In SV40 large T - antigen-positive populations, 
the nutotic fraction (cells in G2/M) was e levated compared to 
normalmelanocytes at a density of2 X 103 cells/cm 2 and remained 
essentially stable even at higher cell densities (Table I). In cultures 
of non-transformed m elan ocytes, the increase ill population density 
was associated with a reduction of cells in the G2/M phase (Table 
I). Similar results w ere observed when cells were harvested after 
one and three doubling times (data not shown). 
T IllS was con firmed by examining the cell-cycle distribution in 
non-synchl'onized cultures of the two different melanocyte popu-
lations (Table II). In those experiments, 68% of tlle nonnaJ 
population was found in GO/Gl (i .e., the quiescent phase), another 
20% was in the S phase and the remaining 12% was undergoing 
mitosis (G2/M phase). Tn cultures ofT- antigen-transformed mela-
nocytes, however, almost twice as m any cells (23%) disp layed a 
mi totic DNA pattem at an y given time (G2/M), 22% were 
progressing through the S phase, whereas the percentage of cells in 
the GO/G1 phase decreased to 55%. These experim en ts indicated 
tha t the number of SV40 large T -antigen-positive cells in nLitosis 
was increased compared to normal melanocytes and remained at an 
elevated level even in more conAu ent cultures, implying that the 
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Figure 3. Northern analysis of normal, SV40 T-antigen-trans-
formed melanocytes and the SK-MEL 28 ntelanoma line shows a 
substantial reduction of tyrosinase mRNA levels in T -antigen-
positive cells . mRNA oflogaritlunically growing cells at passage 3 (higher 
passage number for the melanoma sample) was prepared using the guani-
dinium-isothiocyanate/ces ium chloride gradient m ethod. Five micrograms 
of each sample was electrophoresed on ,Ul 1.4% agarose gel and hybridized 
with the radio labeled DNA insert of pMEL 34 [23] . T he autoradiograph 
(72 h exposure) shows (0) normal human melan ocytes, (b) T-antigen-
transformed melanocyt<;s, and (c) SK-MEL 28 melanoma cells. 
normal constraints that restrict cell growth at high population 
densities was reduced. 
The time needed for T-antigen-expressing m elanocytes to 
progress through the cell cycle was also accelerated , averaging 36 h 
compared to 49 h for normal melanocytes. In the transformants, the 
GO/Gt phase lasted approxim ately 18 ± 4 h (exit of 50% of cells 
from GO/Gl within 9 h) versus 30 ± 6 h in normal melanocytes 
(exit of50% of cells from GO/G1 w ithin 15 h) . No differences were 
seen in the length ofG2/M (9 ± 2 h and 10 :± 2 h for transformed 
and normal melanocytes, respectively) (Table III). From these 
studies, it was concluded that the reduction in the length of the cell 
cycle was caused primarily by a shorten ed G1 phase in the 
transfonnants (Fig 4a, b) . 
Transfo rmed Melanocytes Require Substantially Less bFGF 
and Proliferate Without PMA bFGF is an essential compon ent 
Table I. SV 40 Transformed Melanocyte Cultures 
Contain More Mitotic Cells and Display Less Contact 
Inhibition than Do Normal Melanocytes 
Cells in the G2IM Phase of the Cell Cycle 
Number of Nom1aJ T -Antigen-Expressing 
Cells Seeded" Mclanocytes Melanocytes 
2 X 103 cells/ cm 2 17.4% 27.2% 
4 X 103 ce lls/cm2 12.3% 23.4% 
8 X 103 cells/cm 2 1.9% 20.8'!!o 
( I In contrast to norma.l mclanocytes. transformed cells remaj n hjghly proliferative 
even at incrcasiJlg cdl densities. Normal and T-antigcn-cxpressi ng Illc1:lI1 ocytes were 
plated at the concentrations indicated. and after 72 h , fl ow cytomctry for DNA content 
was performed ;IS detailed ill Materiai.«: alld M('t"ot/s. Perce ntagc valucs represent resu.lts 
from on e experiment of three performed. 
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Table II. SV40 Transformed Melanocytes from Semi-
Confluent, Non-Synchronized Cultures Contain More 
Cells in the GO/G1 Phase of the Cell Cycle than Do 
Normal Melanocytes" 
GO/Gl-Phase S-Phase/, G2IM-Phase 
N O[Olal melanocytes 68% 22% 12% 
T -antigen- expressing 
melanocytes 55% 20% 23% 
f/ F.ACS analysis was conducted in SCJll1cOIlAucnt, logaritlullica11y growing cultures 
of th e samc passage. Flow cytOJ11ctry for DNA con tcnt was performed as detailed in 
NEate-rials a"d Methods. Perccntage values rcprcsent results from onc cxpcriment out of 
three performed. 
/, A-s calculated fr0111 popul ation doubling times in logarithrnicaUy growing cultures. 
for melanocyte mitogenesis [23,24]. Normal melanocytes lack the 
syn thetic capacity for bFGF. Rather they depend on its production 
by exogenous sources (keratinocytes, fibroblasts). In contrast, 
melanoma cells characteristically both synthesize bFGF and re-
spoo d to it in an autocrine m arl11er. Normal melanocytes required 
1 ng/ml purified bFGF to achieve a 50% increase in cell numbers 
ove!" 10 d and lower concentrations (0 - 0.4 ng/ml) led to extensive 
cell d eath. T-antigen-transformation reduced the bFGF require-
ment to 40% (0 .4 ng/ml) of the original level, suggesting endog-
enooS production of this indispensable growth factor. Tlus was 
confirmed by Western blot analysis. bFGF protein appeared as a 
band of 17 kd in samples of T -antigen-transformed m elanocytes 
and melanoma cells that was not detectable in .norma] melanocytes 
(Fig 5). T he ba.nd was more prominent in the m elanoma cells than 
in T-antigen-transformed m elanocytes. In contrast to SK-MEL 28 
cells. comple te independence from exogenous bFGF could not be 
achieved in the T-antigen-transfonned population (Figs 6 and 7). 
Normal melanocytes also require PMA for growth. Omission of 
PMA from the growth m edium results in their rapid senescence 
with flattening and dendrite reduction within 48 h and population 
death within 5 d. Melanoma cell lines, on the other hand, do not 
require this agent for proliferation. Studies were next conducted to 
detet"min e whether T -antigen-positive melanocytes behaved more 
like :normal melanocytes or like melanoma cell lin es in tlus regard. 
Large T - antigen-positive m elanocytes displayed no reduction in 
thei!" proliferative activity in the absence of PM A, although reduced 
dendrite formation w as observed (data not shown). 
T_~tigen-Expressing Melanocytes Display an 'Expanded 
Dopbling Time, but Remain Anchorage-Dependent and 
Nou-Tumorigenic in Nude Mice In normal human epidermis, 
mebl10cytes only rarely undergo mi tosis and their life span il/. ";tm 
is us1.lally Limited to 10 to 60 doublings depending on the age of the 
skin source [18, 25]. T-antigen-transformed cultures of adult skin-
derived melanocytes, however, exlubited a substantial extension of 
theu- life span, at least quadrupling the number of possible passages. 
L~ge T -antigen-transformed m elanocytes were evaluated for 
theu- capacity to undergo anchorage-independent growth as as-
sessed by their ability to grow in soft agar. Like non-transformed 
m el:iJ.l1ocytes, they failed to form cololues in soft agar, whereas 
':Cable III. Transformed Melanocytes Progress More 
~apidly Through the GO/G1 Phase of the Cell Cycle" 
GO/Gl Phase S-Phase/, G2/M Phase 
N orrlla l melanocyte, 30 :!: 6 h 9 :!: 2 h 10 :!: 2 h 
T-anogcn- express ing 
tnelanocytes 16 :!: 4 h 9 :!: 1 h 9:!:2 h 
" Distribu tion of ceLIs in the different stages of the cell cycle: fA CS ana lys is was 
condtlctcd in semiconflucl1t, l og~1Titillnica l1 y growing cul tures of th e same passage. 
Sarnl>Jes 0 ( 0.5 X 10" cells were prepared :IS described ill M"te";"ls ""d Metl, ,,ds. Resul ts 
represent aver:tgcs of three independent experimetlts using cells of dilfc rcnt donors. 
Data ,(eprcscnts the mean :::t: SD. 
I, A.~ c:llcu latcd from popula tion doubl.ing t imes in logarithl11kaUy growing culw.l'cs. 
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Figure 4. In adult melanocytes, SV40 T-antigen tral1sfOrn~atioll 
accelerates the passage through GO/G 1, but does not influence the 
G2/M and S phase of the cell cycle. The flow-cytometric D NA analysis 
quantifies cells ill the respective cycle phase (percen t of the total POPulation) 
in samples taken at various time points. n) Exit times (in hours) from the G1 
phase of the cell cycle in cultures of normal (_) and SV40-transformed 
melanocytes (A) treated with Colcemid (cells blocked in G2IM) . b) Exit 
times (in hours) from the G2/M phase of the cell cycle in cultures of rl.o(maJ 
(_) and SV40-transformed melanocytes (A) treated with Aphidicolitl. (cells 
blocked in G2IM). FACS analysis was performed in three independent sets 
of samples using cells of diJferent donors. T hese arc the results of one of 
three representative experiments. 
SK-MEL 28 melanoma cells proliferated under these conditio ns 
with 30% plating efficiency. 
SV 40 large T -antigen-transformed melanocytes were also exam-
ined for tumorigenicity when injected into nude mice. In patl.els of 
mice givenl1ormalmelanocytes or T-antigen-positive melanocytes, 
there was no growth over a 5-month observation period. In 
contrast, all five animals given SK-MEL 28 melanoma cells devel-
oped tumors at the site of inoculation within 14 d. 
DISCUSSION 
In the present study, the SV40 large T -antigen sequence was used 
to evaluate the growth characteristics and malignant potentjal of 
human melanocytes isolated from normal skin. The rationale for 
tlus line of investigation was based on observations by other 
laboratories that melanoma susceptibWty could be conferred by 
introduction of the SV 40 transgene into melanocytes of transgenic 
mice [19,20] . However, even with tlus matlipulation, conversiot1 of 
melanocytes to melanomas was an infrequent event unless addi-
tional envirOlU11ental factors such as ultravio let radiation [19] or 
wounding of the skin [25,26] were added. T he inability of SV 40 to 
completely transform melanocytes to their malignant counterpart 
raises the question as to what it does do in a functional sel"l.SC to 
facilitate this process. We reasoned that valuable infonnation could 
be obtained by examining its effect on human melanocyte gt-owth 
and progression through the cell cycle. 
Genomic integration of SV40 large T antigen caused significant 
alterations in the growth behavior of these specialized cells. Shifts 
in proliferation kinetics increased the percentage of nutotic cells 
and decreased the duration of melanocytes in the G1 phase (Jf the 
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1 2 3 
Figure 5. T -antigcn-f'xpressing melanocytes acquire the ability to 
synthesize bFGF. Each lane of a 12% PAGE-gel was loaded with 30 p.g 
soluble intracellular protein obtained by detergent lysis (1% Triton X-lOO) 
ofS X 106 cells. Mter electrotransfer to a PVDF membrane (Immobilon P), 
the prote ins were stained with bFGF antibody and visualized using the 
DAKO AEC-substrate system. Lalle 1, SK-MEL 28 cells. Lalle 2, SV40 
T-antigen-transfor1l1ed melanocytes. Lnlle 3, nonnal adult melanocytes . 
cell cycle. T h.i s was accompanied by accelerated doubling times and 
a significantly extended life span ill lIitro. In addition, in striking 
contrast to their normal cOllnterparts, these cells showed reduced 
dependence on bFGF. Expression of tile SV40 large T antigen 
alone, however, proved not to be sufficient to fully establish the 
% increase 60~-----~~--------------------------~ 
40~-------------~~-----------------=--~ 
20 -1---------/ 
·20 .... = -----;7rf!-- -------- - normal human melanocytes --
-+- T-ag positive melanocytes 
-40 -t'''--------------- ~ melanoma line SK-MEL 28 _ 
-60 i------r-----,r-----~----~----_, 
o 0.2 0.4 0.6 0.8 
ng/ml bFGF 
Figure 6. T-anugen-transformed nlelanoeytes require signifi-
cantly less bFGF to proliferate . Effect of various bFGF concentrations 
on the proliferation of normal, SV40 T-an tigen-trallSfon11ed melanocytes 
and the SK-MEL 28 melanoma line. Cell s were p lated at a density of 4 X 
10' cells/em 2 in complete medium containing 0-1 ng/ml bFGF. After 10 d , 
cell s were trypsinized and counted on a hematocytometcr. The increase or 
decrease in cell numbers over the initial seeding concentration is depicted. 
+, T-antigen transformed melanocytes .• , Normal melanocytes .•. SK-
MEL 28 melanoma cell s. 
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Figure 7. Effect of various bFGF concentrations on the growth ofnot"ntal anJ SV40 T-antigen-transformed melanocytes and the SK-MEL 
28 melanoma line. Cells were plated at a density of 4 X 10' cells/cm2 in comlJlet~ medium containing (n , d) no bFGF. b, e) 0.4 ng/ml bFGF. c,j) 1 ng/ml 
bFGF. Pictures were taken after 10 d of culture under selective conditions. Top. normal melanocytes. BO/lOIII. T-antigen expressing. Phase-contrast 
photomicrographs. ba,.s. 50 /-tm for a and d; 15 /-tm for b, c, e and f 
malignant phenotype. Transformed melanocytes failed to foml 
colonies in soft agar. they were unable to initiate tumors in nude 
mice. and they eventualJy underwent senescence. 
These findings in ill. vitro transformed human melanocytes are 
compatible with those obtained if I vivo in transgenic mice in which 
the SV 40 transgene was specificalJy targeted to melanocytes 
[19 ,20]. In those animals. an increase in the number of proliferating 
me lanocytes was detected in vi/lo [19]. and, when they were 
rerl"lOved and placed in culture. they exhibited an increased prolif-
er~tive activity [20] . Apart from putative growth-stimulatory fac-
tors associated with wound healing, the administration of a single 
dose of 0.7 mJ/cm2 UVB-non-tumorigenic for normal celJs-
confecred anchorage-independence and, with slightly higher doses, 
a malignant phenotype to melanocytes from these transgenic mice. 
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The SV40 Iarge T antigen has added a new dimension to the 
oncogene-centered model of human carcinogenesis. in large part 
because of its ability to inactivate the protein product of the p53 
tumor suppressor gene [15 .27] . Stable complexes are fonned between 
the SV 40 large T antigen and with highly conserved regions of the 
suppressor protein that exert specific growth-regulatory fimctions 
[15.27.28]. T hese domains contain the mutational " hot spots" fowld 
to be the most common genetic aIterations in neoplastic development 
[29]. To date. binding ofT antigen to p53 is considered to be a crucial 
step in the initiation of the transfomled phenotype in non-pennissive 
cells [29-32]. It thus seems reasonable to hypothesize that SV40 large 
T antigen mediates its effects on l11elanocytes largely tlu-ough its 
interactions with p53. 
Several immullohistochemical [33-36] as well as molecular bio-
logic approaches [35.37] provide evidence that p53 loss of function 
is involved in the development of malignant melanoma. Howe ver. 
significant controversy exists regarding the timing of p53 overex-
pression during this multistep process. Whereas studies by Akslen 
and Morkve [33) and Stretch et al [35] reveal p53 expression in a 
m;tiority of primary melanomas (70% and 97%, respectively) , thus 
indicating an ea rly event in the tumor evolution. other authors 
[34,37] observe increasing p53 immunoreactivity or polyme rase 
chain reaction-detectable mutations with m ore advanced stages of 
the disease. O ur data would sugges t that alterations in turnor-
suppressor genes play a critical role early in melanoma deve lop-
ment. However, it is clear th at a dynamic biologic process as 
complex as the neoplastic microevolution needs additional fun c-
tional studies to eva luate the relevance of existin g experime ntal 
data . 
In normal cells , elevated levels of p53 during G1 indicate a 
"checkpoint" phase of D NA control allowing the repair of poten-
tial mutations or the induction of apoptosis in cases of irrepaL-able 
damage [14 ,38]. In our system, much £1ster progression of SV40 
large T -antigen-transformed melanocytes through this stage of the 
ce lJ cycle suggests the lack of active p53, a consistent findirtg in 
other T -antigen-expressing cul tures as well [21]. In addition, 
transformation with the SV40 large T antigen stimulated quies cent 
cells to re-enter the cell cycle, an effect reflected by a hig he r 
percentage of mitotic cells (G2 peak) and smaller GOIGl fra ction in 
Ollr flow-cytom etric ana lysis. 
SV 40 large T -antigen complexes w ith at least four other cellu lar 
proteins, including DNA polymerase a 39 , the product of the 
Rb-genell, a 73-kd heat shock-like protein [40] and another 
cellular proteill ranging from 107 to 120 kd [41]. However, various 
experiments with t1"l1ncated [31] or mutated [9,12] T proteins have 
clearly demonstrated that an intact p53-binding site is indispensable 
for the transforming effect of the simian virus oncogene [3 2]. 
Autocrine production of bFGF is a sensitive marker for mel <l no-
cytic cells acquiring malignant potential [23 ,24 ,42]. Melanoma cell 
liJles proliferate without the addition of this m elanocyte mitoge n to 
cell cultures, and in melanocytes an increasing ability to synthesize 
bFGF parallels the capacity of those cells to grow in a semisolid 
milieu [1.8]. Further support for the relationship betw een bFGF and 
the malignant pote ntial of m elanocytes has come fi'om studies in 
which an anti-sense bFGF construct was introduced into hU]TIan 
melanoma cells. Such an experimental manipulation inhibited the 
proliferative activity of those cells and retarded their ,U1chorage-
independent growth in semi-solid m edium [42]. C onsistent with 
the hypotheses generated from those studies, o ur SV40 large 
T -antigen-positive melaJl0cytes not only maintained their growth 
dependence on bFGF but also rem ained an chorage dependent. This 
would suggest that SV 40 large T -antigen-transfonned me1anocytes 
are at an intermediate stage between normal and malignant cells. 
Large T -antigen-expressing melanoc)'tes remained morpho log-
ically indisting uishable fi'om non-transformed cells, indicating that 
the SV40 large T antigen confers predominantly growth-related 
alterations on melanocytes. T his contrasts to the findings of J al11-
brosic, who reported signifi cant chaJl ges in melanocyte mO"phol-
ogy upon T -antigen transformation [1 7] w ith loss of dendri tes and 
epithelioid growth pattern . However, in that study, cells were 
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selected by proliferation in the absence of PM A, which is known to 
induce dendrite formation [43] and might explain diKerences i.n the 
two studies . Maintenance of the original morphology has also been 
observed in p53-negative osteosarcoma following transfectioll of a 
mutant p53 gene [44], thus i.ndicating that its loss of function is not 
related to cellular appearance. 
W e also found that contact inhibi tion , another growth-regula-
tory factor, was also suppressed in large T - antigen-positive m ela-
nocytes . Growth to highly confluent monolayers has b een observed 
in other sinlilm'ly transformed lines [8-10,45]. This, too, has been 
attributed to in teractions with the p53 protein product. Defective 
mutants ofT antigen lacking the binding site for p53 fai l to enhance 
the saturation density in transform ed fibroblasts , wh ereas Rb-site 
defi cient yet p53-intact T mutants induced saturation densities 
identical to wild-type T antigen [45]. In addition, transfection of 
Saos-2 cells with a mutant p53 gene resulted in saturation densities 
that were up to fiv e times greater than normal levels [44]. Transfer 
of wild-type forms significantly blocked the further growth of 
tumor cells [44). 
In summary, tlle accumulated evidence suggests that by reducing 
the proportion of m elanocytes in the G1 phase of the cell cycle and 
by decreasing their dependence on exogenous g rowtll factors, viral 
oncogenes such as the SV40 large T antigen predispose tllls 
specialized cell population to additionaI insults that eventuate in 
their conversion into fully malign ant cells. 
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Knplnll .li,r lIis niticn l rCll iellJ 'if ,lle III nlll,scripl . A . C. H . is tile recipiellt '!( n research 
fellolllsllip grolllfrO/ll Ill e A lll erienll De","ntology Po/ lIIdoti,,,,. K. Z. is til l' recipi""t 
of n fellol/ls/tip grolllj imll Il, e OPG, Genll nllY. T llis 'I'ork IIIns SIl]>p0l1ed by N TH 
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